Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O1CW
|
||||
Former ID |
DNC011059
|
||||
Drug Name |
GNF-PF-2700
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530966] | ||
Structure |
Download2D MOL |
||||
Formula |
C12H15N5O
|
||||
Canonical SMILES |
CCOC1=CC=CC2=C1N=C(N=C2C)N=C(N)N
|
||||
InChI |
1S/C12H15N5O/c1-3-18-9-6-4-5-8-7(2)15-12(16-10(8)9)17-11(13)14/h4-6H,3H2,1-2H3,(H4,13,14,15,16,17)
|
||||
InChIKey |
NNFBJZLFJMBVGQ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2b receptor | Target Info | Inhibitor | [530966] | |
Adenosine A2a receptor | Target Info | Inhibitor | [530966] | ||
Adenosine A1 receptor | Target Info | Inhibitor | [530966] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Calcium signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Vascular smooth muscle contraction | |||||
Alcoholismhsa04015:Rap1 signaling pathway | |||||
cAMP signaling pathway | |||||
Parkinson's disease | |||||
Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Morphine addiction | |||||
Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.